2015
DOI: 10.7860/jcdr/2015/13452.6652
|View full text |Cite
|
Sign up to set email alerts
|

Adverse Drug Reaction Profile in Patients on Anti-tubercular Treatment Alone and in Combination with Highly Active Antiretroviral Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
14
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(17 citation statements)
references
References 17 publications
3
14
0
Order By: Relevance
“…Patients co-infected with HIV had 3 times more risk than patients without HIV. Similar results were seen in a study by sadiq s et al 27 and fellay J et al 28 showed that concomitant HAART and ATT results in more ADRs. Most of the ADRs in patients with HIV were occurred within a year.…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…Patients co-infected with HIV had 3 times more risk than patients without HIV. Similar results were seen in a study by sadiq s et al 27 and fellay J et al 28 showed that concomitant HAART and ATT results in more ADRs. Most of the ADRs in patients with HIV were occurred within a year.…”
Section: Discussionsupporting
confidence: 88%
“…Most of the ADRs 215(69.8%) were having probable relationship with the suspected drugs followed by possible 93(30.19%) which is dissimilar with the studies where most of the ADRs were having possible relationship with suspected drugs. 27,40 Isoniazid was topped the list of anti-tubercular drugs causing ADRs (32.47%) followed by pyrazinamide (27.59%), rifampicin (24.36%), ethambutol (11.36%) and streptomycin (44.22%). 41 INH was mainly responsible for causing Tingling and numbness (11.03%).…”
Section: Discussionmentioning
confidence: 99%
“…35 However, a course of anti-TB drugs usually lasts >6 months, 36 and there can be adverse drug reactions, the most common of which is upper abdominal pain. 37 In recent years, many studies on multidrug-resistant M. tuberculosis have reported the challenges for anti-TB drug therapies. 38 Further research is required to develop new treatment protocols.…”
Section: Discussionmentioning
confidence: 99%
“…These findings were same as observed in a study done by Sadiq et al in patients on antiretroviral with concomitant antitubercular therapy. 18 Agu et al, found 50% of ADRs were reported by patients who were taking cotrimoxazole concomitantly with antiretroviral drugs (ARVs).…”
Section: Frequencymentioning
confidence: 99%